VivoSim Labs, Inc. share price logo

VivoSim Labs, Inc. Share Price

NASDAQ: VIVS

Small Cap

$1.62

+0.12

(+8.00%)

as on

VivoSim Labs, Inc. Stock Performance

as on April 18, 2026 at 6:58 am IST

  • Day's Low

    Day's High

    $1.51
    $1.89
    downward going graph

    6.79%

    Downside

    16.67%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.25
    $5.30
    downward going graph

    22.84%

    Downside

    227.16%

    Upside

    downward going graph

VivoSim Labs, Inc. share price movements today

Previous Close
$1.50
Open
$1.54
Volume
356.7K
Day's Low - High
$1.51 - $1.89
52 Week Low - High
$1.25 - $5.30

VivoSim Labs, Inc. Historical Returns

1 Month Return
-16.67 %
3 Month Return
-28.23 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

VivoSim Labs, Inc. Stock Fundamentals & Key Indicators

Check VivoSim Labs, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.3M

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0.85

Industry PE ratio

-3.402487684729064

PEG Ratio

0

Return On Equity TTM

-51.07%

VivoSim Labs, Inc. Stock Valuation

Track how VivoSim Labs, Inc. P/E has moved over time to understand its valuation trends.

VivoSim Labs, Inc. in the last 5 years

  • Overview

  • Trends

Lowest (-12.46x)

September 30, 2025

Industry (-3.40x)

April 17, 2026

Today (0.85x)

April 17, 2026

Highest (2.25x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: 0.85x

VivoSim Labs, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of VivoSim Labs, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
VivoSim Labs, Inc. image
VivoSim Labs, Inc.
NA$4.3MNA0.850.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$42.7B130.51%136.818.45%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$110.8B98.57%28.4232.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$36.8BNA129.845.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$78.9B48.43%17.9831.41%

VivoSim Labs, Inc. Stock’s Investor Sentiment and Interest

Search interest for VivoSim Labs, Inc. Stock has decreased by -27% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-27% versus previous 30 day period

VivoSim Labs, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
0
0
0
0
0
0
0
0
0
Gross Profit
0
0
0
0
0
0
0
0
0
Operating Income
-3
-3
-3
-2
-3
-3
-2
-2
-2
EBITDA
-3
-3
-3
-2
-3
6
-2
-2
-2
Interest Expense
-
-
-
-
0
0
0
-
0
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-3
-3
-3
-2
-3
6
-2
-2
-2
Income Tax Expense
-
-
0
-
-
-
-
0
-
Net Income
-3
-3
-3
-2
-3
6
-2
-2
-2
Net Profit Margin
-72080.00%
-10500.00%
-8574.36%
-8496.67%
-14362.50%
13435.29%
-7683.78%
-9089.29%
-10350.00%

VivoSim Labs, Inc. Annual Profit & Loss

All numbers in Millions USD

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Total Revenue
1
4
4
3
2
-
1
0
0
0
Gross Profit
1
3
3
2
1
-
1
0
0
0
Operating Income
-38
-38
-35
-27
-21
-16
-11
-17
-15
-12
EBITDA
-37
-37
-34
-26
-20
-16
-11
-17
-14
-2
Interest Expense
-
-
-
-
-
-
-
-
-
0
Depreciation
-
-
-
-
-
0
0
0
0
0
Income Before Tax
-38
-38
-34
-26
-18
-16
-11
-17
-14
-2
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-38
-38
-34
-26
-18
-16
-11
-17
-14
-2
Net Profit Margin
-2601.15%
-908.91%
-756.09%
-861.70%
-852.00%
0.00%
-763.20%
-4664.59%
-13459.63%
-1727.78%

VivoSim Labs, Inc. Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-3
-3
-3
-2
-3
6
-2
-2
-2
Operating Cash Flow
-3
-2
-2
-2
-1
-2
-3
-2
-2
Investing Cash Flow
0
0
0
-
0
9
-
-
-
Financing Cash Flow
1
0
6
0
0
3
1
-
0
Change in Cash
-2
-2
3
-3
-2
10
-2
-2
-2

VivoSim Labs, Inc. Annual Cash Flow

All numbers in Millions USD

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Income
-38
-34
-26
-18
-16
-11
-17
-14
-2
Operating Cash Flow
-29
-28
-20
-14
-13
-8
-12
-14
-9
Investing Cash Flow
-1
0
0
0
0
0
0
0
9
Financing Cash Flow
31
10
13
4
23
0
-
1
8
Change in Cash
0
-19
-7
-9
10
-8
-13
-12
8

Insights on VivoSim Labs, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 21.1% return, outperforming this stock by 115.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Beone Medicines Ltd has given 38.8% return, outperforming this stock by 51.6%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -2.54M → -2.69M (in $), with an average decrease of 5.7% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 4 quarters, 51.0K → 26.0K (in $), with an average decrease of 19.6% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, VIVS stock has moved down by -16.7%

About VivoSim Labs, Inc.

VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models; and bespoke services in the areas of investigational toxicology, mechanism of drug action elucidation, and other applications of complex human tissue models. The company also provides liver toxicology predictive screening and research services, as well as works on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at various stages of drug development; and uses its proprietary technologies to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function, and disease. In addition, it offers 3D human tissue platform that develops novel human normal and disease models using high throughput systems, bioprinted, and flow/stretch capable 3D systems. The company was formerly known as Organovo Holdings, Inc. and changed its name to VivoSim Labs, Inc. in April 2025. VivoSim Labs, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
OrganisationVivoSim Labs, Inc.
Headquarters11555 Sorrento Valley Road, San Diego, CA, United States, 92121
IndustryBiotechnology
CEOMr. Keith E. Murphy
E-voting on sharesClick here to vote

Key Management of VivoSim Labs, Inc.

Name

Title

Mr. Tony Lialin

Chief Commercial Officer

Mr. Keith E. Murphy

Executive Chairman & Corporate Secretary

Mr. Norman Staskey

President, CFO & Principal Financial Officer

Dr. Amar A. Sethi M.D., Ph.D.

Chief Scientific Officer

FAQs

What is VivoSim Labs, Inc. share price today?

VivoSim Labs, Inc. share price today is $1.62 as on at the close of the market. VivoSim Labs, Inc. share today touched a day high of $1.89 and a low of $1.51.

What is the 52 week high and 52 week low for VivoSim Labs, Inc. share?

VivoSim Labs, Inc. share touched a 52 week high of $5.3 on and a 52 week low of $1.25 on . VivoSim Labs, Inc. stock price today i.e. is closed at $1.62,which is 69.43% down from its 52 week high and 29.60% up from its 52 week low.

What is VivoSim Labs, Inc.'s market capitalisation today?

VivoSim Labs, Inc. market capitalisation is $0.00T as on .

How to invest in VivoSim Labs, Inc. Stock (VIVS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for VivoSim Labs, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in VivoSim Labs, Inc. Shares that will get you 0.9259 shares as per VivoSim Labs, Inc. share price of $1.62 per share as on April 18, 2026 at 1:28 am IST.

What is the minimum amount required to buy VivoSim Labs, Inc. Stock (VIVS) from India?

Indian investors can start investing in VivoSim Labs, Inc. (VIVS) shares with as little as ₹92.768 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹927.68 in VivoSim Labs, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on VivoSim Labs, Inc. share’s latest price of $1.62 as on April 18, 2026 at 1:28 am IST, you will get 6.1728 shares of VivoSim Labs, Inc.. Learn more about fractional shares .